Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

1,124 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity ▴	Revenue growth	Diluted EPS
LAW	CS Disco, Inc. Services · Year ended 2025-12-31 · USD	$156.85M	-$44.37M	-28.3%	-34.6%	8.3%	-$0.72
AGIO	Agios Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$54.03M	-$412.78M	-764.0%	-34.6%	48.0%	-$7.12
PRAX	Praxis Precision Medicines, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$303.27M	n/a	-34.5%	-100.0%	-$13.48
CBLL	Ceribell, Inc. Manufacturing · Year ended 2025-12-31 · USD	$89.06M	-$53.41M	-60.0%	-34.4%	36.1%	-$1.46
BCAX	Bicara Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$137.95M	n/a	-34.4%	n/a	-$2.52
CAPR	Capricor Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$105.04M	n/a	-34.4%	-100.0%	-$2.26
NGNE	Neurogene Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$90.35M	n/a	-34.1%	-100.0%	-$4.24
IMA	ImageneBio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$800.0K	-$45.35M	n/m	-34.1%	-77.1%	-$9.64
TMQ	Trilogy Metals Inc. Mining · Year ended 2025-11-30 · USD	n/a	-$42.24M	n/a	-34.0%	n/a	-$0.26
SES	SES AI Corp Manufacturing · Year ended 2025-12-31 · USD	$21.00M	-$73.04M	-347.8%	-34.0%	929.4%	-$0.22
OLMA	Olema Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$162.45M	n/a	-33.9%	n/a	-$1.87
CMPX	Compass Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$66.49M	n/a	-33.8%	-100.0%	n/a
ORIC	Oric Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$129.47M	n/a	-33.7%	n/a	-$1.47
EVMN	Evommune, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.00M	-$68.87M	-529.8%	-33.5%	85.7%	-$11.22
IMNM	Immunome Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.94M	-$212.39M	n/m	-33.5%	-23.2%	-$2.43
NKTX	Nkarta, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$104.08M	n/a	-33.3%	n/a	-$1.41
DVLT	Datavault AI Inc. Services · Year ended 2025-12-31 · USD	$39.09M	-$78.99M	-202.1%	-33.2%	n/m	-$0.52
ACOG	Alpha Cognition Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.22M	-$20.67M	-202.2%	-33.1%	n/a	-$1.18
NAVN	Navan, Inc. Services · Year ended 2026-01-31 · USD	$702.26M	-$398.03M	-56.7%	-32.9%	30.8%	-$4.07
DNTH	Dianthus Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.04M	-$162.34M	n/m	-32.9%	-67.3%	-$4.20
DSGN	Design Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$69.79M	n/a	-32.8%	n/a	-$1.22
MRNA	Moderna, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.94B	-$2.82B	-145.2%	-32.6%	-39.9%	-$7.26
BBOT	BridgeBio Oncology Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$134.04M	n/a	-32.6%	n/a	-$4.30
XBIT	XBiotech Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$45.54M	n/a	-32.4%	n/a	-$1.49
EWTX	Edgewise Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$167.79M	n/a	-32.1%	n/a	-$1.63

Rows per page: 2550 100